ImmunoPrecise Antibodies Ltd (IPA)
1.17
+0.04
(+3.70%)
USD |
NASDAQ |
May 22, 16:00
1.185
+0.02
(+1.28%)
After-Hours: 20:00
ImmunoPrecise Antibodies Total Assets (Quarterly): 58.71M for Jan. 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | 58.71M |
| October 31, 2023 | 54.67M |
| July 31, 2023 | 57.77M |
| April 30, 2023 | 56.97M |
| January 31, 2023 | 61.59M |
| October 31, 2022 | 60.81M |
| July 31, 2022 | 61.67M |
| April 30, 2022 | 72.36M |
| January 31, 2022 | 44.23M |
| October 31, 2021 | 48.68M |
| July 31, 2021 | 51.64M |
| April 30, 2021 | 54.54M |
| January 31, 2021 | 34.11M |
| October 31, 2020 | 32.80M |
| July 31, 2020 | 24.91M |
| April 30, 2020 | 19.48M |
| January 31, 2020 | 19.34M |
| October 31, 2019 | 20.03M |
| July 31, 2019 | 21.19M |
| April 30, 2019 | 21.15M |
| January 31, 2019 | 22.02M |
| October 31, 2018 | 23.66M |
| July 31, 2018 | 18.33M |
| April 30, 2018 | 19.13M |
| January 31, 2018 | 10.60M |
| Date | Value |
|---|---|
| October 31, 2017 | 10.33M |
| July 31, 2017 | 2.413M |
| April 30, 2017 | 2.882M |
| January 31, 2017 | 3.492M |
| September 30, 2016 | 0.3961M |
| June 30, 2016 | 0.018M |
| March 31, 2016 | 0.0199M |
| December 31, 2015 | 0.0111M |
| September 30, 2015 | 0.0147M |
| June 30, 2015 | 0.0251M |
| March 31, 2015 | 0.0353M |
| December 31, 2014 | 0.0397M |
| September 30, 2014 | 0.0448M |
| June 30, 2014 | 0.0958M |
| March 31, 2014 | 0.117M |
| December 31, 2013 | 0.1336M |
| September 30, 2013 | 0.1786M |
| June 30, 2013 | 0.0357M |
| March 31, 2013 | 0.0374M |
| December 31, 2012 | 0.0502M |
| September 30, 2012 | 0.0742M |
| June 30, 2012 | 0.079M |
| March 31, 2012 | 0.1064M |
| December 31, 2011 | 0.0913M |
| September 30, 2011 | 0.1032M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
19.34M
Minimum
Jan 2020
72.36M
Maximum
Apr 2022
45.03M
Average
51.64M
Median
Jul 2021
Total Assets (Quarterly) Benchmarks
| Acasti Pharma Inc | 76.18M |
| Aurinia Pharmaceuticals Inc | 548.06M |
| Edesa Biotech Inc | 6.475M |
| Lexaria Bioscience Corp | 6.352M |
| Xenon Pharmaceuticals Inc | 919.02M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 21.54M |
| Shareholders Equity (Quarterly) | 37.17M |
| Current Ratio | 1.657 |